Zylocyp Syrup is a multi-ingredient pharmaceutical formulation containing Cyproheptadine (2mg/5ml), Tricholine Citrate (275mg/5ml), and Sorbitol (3.575gm/5ml), designed to provide symptomatic relief in various clinical conditions. Cyproheptadine, a potent antihistamine with antiserotonergic properties, is effective in managing allergic reactions, including rhinitis, urticaria, and pruritus, by blocking histamine H1 receptors. Additionally, it is utilized as an appetite stimulant in cases of anorexia and cachexia. Tricholine Citrate acts as a choline precursor and hepatoprotective agent, facilitating lipid metabolism and promoting liver function, thereby supporting detoxification processes and improving overall metabolic balance. Sorbitol serves as a sweetening and stabilizing agent, enhancing palatability and ensuring consistent dosing. Zylocyp Syrup is indicated for patients requiring combined antihistaminic and hepatoprotective therapy, particularly where appetite stimulation and liver support are desired. The syrup formulation allows for ease of administration, especially in pediatric and geriatric populations. Dosage and duration of therapy should be tailored according to the patient’s clinical condition and response, under medical supervision. Contraindications include hypersensitivity to any component and caution is advised in patients with hepatic or renal impairment. Adverse effects may include drowsiness, dry mouth, and gastrointestinal disturbances.